Skip to main content
Erschienen in: Urolithiasis 2/2014

01.04.2014 | Original Paper

Antioxidants inhibition of high plasma androgenic markers in the pathogenesis of ethylene glycol (EG)-induced nephrolithiasis in Wistar rats

verfasst von: Mohammad Reza Naghii, Mahmood Mofid, Mehdi Hedayati, Kazem Khalagi

Erschienen in: Urolithiasis | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Abstract

The association between serum gonadal steroids and urolithiasis in males received only limited attention. Calcium oxalate urolithiasis is induced by administration of ethylene glycol in drinking water. It appears that the administration of natural antioxidants has been used to protect against nephrolithiasis in human and experimental animals. The purpose is to study the potential role of antioxidants as inhibitors of high plasma androgenic markers or hyperandrogenicity in the pathogenesis of ethylene glycol-induced nephrolithiasis in Wistar rats. Male Wistar rats were studied in 4-week period. Group 1 (control) was fed a standard commercial diet. Group 2 received the same diet with 0.5 % of ethylene glycol. Group 3 received EG plus the diet and water added with antioxidant nutrients and lime juice as the dietary source of citrate. Group 4 and Group 5 were treated similar to Group 2 and Group 3 with 0.75 % of ethylene glycol. For antioxidant supplementation, the standard diet enriched with 4,000.0 μg vitamin E and 1,500.0 IU vitamin A for each rat per day added to the diet once a week, and provided daily with 5.0 mg vitamin C, 400.0 μg vitamin B6, 20.0 μg selenium, 12.0 mg zinc, and 2.0 mg boron for each rat per day in their drinking water. After treatment period, collection of blood was performed and kidneys were removed and used for histopathological examination. The results based on various assays, measuring size of crystal deposition, and histological examinations showed that high concentration of androgens acts as promoter for the formation of renal calculi due to ethylene glycol consumption and the inhibitory role of antioxidant complex in the formation of renal calculi disease. Data revealed that the size and the mean number of crystal deposits determined in EG 0.75 % treated groups (G4) were significantly higher than the EG-treated groups, added with antioxidant nutrients and lime juice (G5). The mean concentration of androgens in Group 4 increased after EG 0.75 % administration, and decreased after antioxidants supplementation in Group 5. Elevated concentration of androgens (as promoters of the formation of renal calculi) as a result of EG consumption and their decreasing following antioxidant supplementations along with the slight decrease in malondialdehyde level provides a scientific rational for preventive and treatment roles of antioxidant nutrient complex in kidney stone disease.
Literatur
2.
Zurück zum Zitat Fan J, Glass MA, Chandhoke PS (1989) Effect of castration and finasteride on urinary oxalate excretion in male rats. Urol Res 26:71–75CrossRef Fan J, Glass MA, Chandhoke PS (1989) Effect of castration and finasteride on urinary oxalate excretion in male rats. Urol Res 26:71–75CrossRef
3.
Zurück zum Zitat Patel P, Patel M, Saralai M, Gandhi T (2012) Antiurolithiatic effects of Solanum xanthocarpum fruit extract on ethylene-glycol-induced nephrolithiasis in rats. J Young Pharm 4:164–170PubMedCentralPubMedCrossRef Patel P, Patel M, Saralai M, Gandhi T (2012) Antiurolithiatic effects of Solanum xanthocarpum fruit extract on ethylene-glycol-induced nephrolithiasis in rats. J Young Pharm 4:164–170PubMedCentralPubMedCrossRef
4.
Zurück zum Zitat Lee YH, Huang WC, Huang JK, Chang LS (1996) Testosterone enhances whereas estrogen inhibits calcium oxalate stone formation in ethylene glycol treated rats. J Urol 156:502–505PubMedCrossRef Lee YH, Huang WC, Huang JK, Chang LS (1996) Testosterone enhances whereas estrogen inhibits calcium oxalate stone formation in ethylene glycol treated rats. J Urol 156:502–505PubMedCrossRef
5.
Zurück zum Zitat Yoshioka I, Tsujihata M, Momohara C, Akanae W, Nonomura N, Okuyama A (2010) Effect of sex hormones on crystal formation in a stone-forming rat model. Urology 75:907–913PubMedCrossRef Yoshioka I, Tsujihata M, Momohara C, Akanae W, Nonomura N, Okuyama A (2010) Effect of sex hormones on crystal formation in a stone-forming rat model. Urology 75:907–913PubMedCrossRef
6.
Zurück zum Zitat Yagisawa T, Ito F, Osaka Y, Amano H, Kobayashi C, Toma H (2001) The influence of sex hormones on renal osteopontin expression and urinary constituents in experimental urolithiasis. J Urol 166:1078–1082PubMedCrossRef Yagisawa T, Ito F, Osaka Y, Amano H, Kobayashi C, Toma H (2001) The influence of sex hormones on renal osteopontin expression and urinary constituents in experimental urolithiasis. J Urol 166:1078–1082PubMedCrossRef
8.
Zurück zum Zitat Naziroglu M, Karaoğlu A, Aksoy AO (2004) Selenium and high dose vitamin E administration protects cisplatin-induced oxidative damage to renal, liver and lens tissues in rats. Toxicology 195:221–230PubMedCrossRef Naziroglu M, Karaoğlu A, Aksoy AO (2004) Selenium and high dose vitamin E administration protects cisplatin-induced oxidative damage to renal, liver and lens tissues in rats. Toxicology 195:221–230PubMedCrossRef
9.
Zurück zum Zitat Huang HS, Ma MC, Chen J (2009) Low-vitamin E diet exacerbates calcium oxalate crystal formation via enhanced oxidative stress in rat hyperoxaluric kidney. Am J Physiol Renal Physiol 296:F34–F45PubMedCrossRef Huang HS, Ma MC, Chen J (2009) Low-vitamin E diet exacerbates calcium oxalate crystal formation via enhanced oxidative stress in rat hyperoxaluric kidney. Am J Physiol Renal Physiol 296:F34–F45PubMedCrossRef
10.
Zurück zum Zitat Santhosh Kumar M, Selvam R (2003) Supplementation of vitamin E and selenium prevents hyperoxaluria in experimental urolithic rats. J Nutr Biochem 14:306–313PubMedCrossRef Santhosh Kumar M, Selvam R (2003) Supplementation of vitamin E and selenium prevents hyperoxaluria in experimental urolithic rats. J Nutr Biochem 14:306–313PubMedCrossRef
11.
Zurück zum Zitat Bardaoui M, Sakly R, Neffat F, Najjar MF, El Hani A (2010) Effect of vitamin A supplemented diet on calcium oxalate renal stone formation in rats. Exp Toxicol Pathol 62:573–576PubMedCrossRef Bardaoui M, Sakly R, Neffat F, Najjar MF, El Hani A (2010) Effect of vitamin A supplemented diet on calcium oxalate renal stone formation in rats. Exp Toxicol Pathol 62:573–576PubMedCrossRef
12.
Zurück zum Zitat Selvam R (2002) Calcium oxalate stone disease: role of lipid peroxidation and antioxidants. Urol Res 30:35–47PubMedCrossRef Selvam R (2002) Calcium oxalate stone disease: role of lipid peroxidation and antioxidants. Urol Res 30:35–47PubMedCrossRef
13.
Zurück zum Zitat Ortiz-Alvarado O, Miyaoka R, Kriedberg C, Moeding A, Stessman M, Monga M (2011) Pyridoxine and dietary counseling for the management of idiopathic hyperoxaluria in stone-forming patients. Urology 77:1054–1058PubMedCrossRef Ortiz-Alvarado O, Miyaoka R, Kriedberg C, Moeding A, Stessman M, Monga M (2011) Pyridoxine and dietary counseling for the management of idiopathic hyperoxaluria in stone-forming patients. Urology 77:1054–1058PubMedCrossRef
14.
Zurück zum Zitat Atakan IH, Kaplan M, Seren G, Aktoz T, Gül H, Inci O (2007) Serum, urinary and stone zinc, iron, magnesium and copper levels in idiopathic calcium oxalate stone patients. Int Urol Nephrol 39:351–356PubMedCrossRef Atakan IH, Kaplan M, Seren G, Aktoz T, Gül H, Inci O (2007) Serum, urinary and stone zinc, iron, magnesium and copper levels in idiopathic calcium oxalate stone patients. Int Urol Nephrol 39:351–356PubMedCrossRef
15.
Zurück zum Zitat Naghii MR, Einollahi B, Rostami Z (2012) Preliminary evidence hints at a protective role for boron in urolithiasis. J Altern Complement Med 18:207–209PubMedCrossRef Naghii MR, Einollahi B, Rostami Z (2012) Preliminary evidence hints at a protective role for boron in urolithiasis. J Altern Complement Med 18:207–209PubMedCrossRef
16.
Zurück zum Zitat Touhami M, Laroubi A, Elhabazi K, Loubna F, Zrara I, Eljahiri Y et al (2007) Lemon juice has protective activity in a rat urolithiasis model. BMC Urol 7:18PubMedCentralPubMedCrossRef Touhami M, Laroubi A, Elhabazi K, Loubna F, Zrara I, Eljahiri Y et al (2007) Lemon juice has protective activity in a rat urolithiasis model. BMC Urol 7:18PubMedCentralPubMedCrossRef
17.
Zurück zum Zitat Travison TG, Araujo AB, Hall SA, McKinlay JB (2009) Temporal trends in testosterone levels and treatment in older men. Curr Opin Endocrinol Diabetes Obes 16:211–217PubMedCrossRef Travison TG, Araujo AB, Hall SA, McKinlay JB (2009) Temporal trends in testosterone levels and treatment in older men. Curr Opin Endocrinol Diabetes Obes 16:211–217PubMedCrossRef
18.
Zurück zum Zitat Li JY, Zhou T, Gao X, Xu C, Sun Y, Peng Y et al (2010) Testosterone and androgen receptor in human nephrolithiasis. J Urol 184:2360–2363PubMedCrossRef Li JY, Zhou T, Gao X, Xu C, Sun Y, Peng Y et al (2010) Testosterone and androgen receptor in human nephrolithiasis. J Urol 184:2360–2363PubMedCrossRef
19.
Zurück zum Zitat Finlayson B (1974) Symposium on renal lithiasis. Renal lithiasis in review. Urol Clin North Am 1:181–212PubMed Finlayson B (1974) Symposium on renal lithiasis. Renal lithiasis in review. Urol Clin North Am 1:181–212PubMed
20.
Zurück zum Zitat Curhan GC (1999) Epidemiologic evidence for the role of oxalate in idiopathic nephrolithiasis. J Endourol 13:629–631PubMedCrossRef Curhan GC (1999) Epidemiologic evidence for the role of oxalate in idiopathic nephrolithiasis. J Endourol 13:629–631PubMedCrossRef
21.
Zurück zum Zitat Fan J, Chandhoke PS, Grampsas SA (1999) Role of sex hormones in experimental calcium oxalate nephrolithiasis. J Am Soc Nephrol suppl 14:S376–S380 Fan J, Chandhoke PS, Grampsas SA (1999) Role of sex hormones in experimental calcium oxalate nephrolithiasis. J Am Soc Nephrol suppl 14:S376–S380
22.
Zurück zum Zitat Naghii MR, Hedayati M (2010) Determinant role of gonadal sex hormones in the pathogenesis of urolithiasis in a male subject—a document for male predominancy (case study). Endocr Regul 44:143–146PubMedCrossRef Naghii MR, Hedayati M (2010) Determinant role of gonadal sex hormones in the pathogenesis of urolithiasis in a male subject—a document for male predominancy (case study). Endocr Regul 44:143–146PubMedCrossRef
23.
Zurück zum Zitat Watson JM, Shrewsberry AB, Taghechian S, Goodman M, Pattaras JG, Ritenour CW et al (2010) Serum testosterone may be associated with calcium oxalate urolithogenesis. J Endourol 24:1183–1187PubMedCrossRef Watson JM, Shrewsberry AB, Taghechian S, Goodman M, Pattaras JG, Ritenour CW et al (2010) Serum testosterone may be associated with calcium oxalate urolithogenesis. J Endourol 24:1183–1187PubMedCrossRef
24.
Zurück zum Zitat Shakhssalim N, Gilani KR, Parvin M, Torbati PM, Kashi AH, Azadvari M et al (2010) An assessment of parathyroid hormone, calcitonin, 1,25 (OH)2 vitamin D3, estradiol and testosterone in men with active calcium stone disease and evaluation of its biochemical risk factors. Urol Res 39:1–7PubMedCrossRef Shakhssalim N, Gilani KR, Parvin M, Torbati PM, Kashi AH, Azadvari M et al (2010) An assessment of parathyroid hormone, calcitonin, 1,25 (OH)2 vitamin D3, estradiol and testosterone in men with active calcium stone disease and evaluation of its biochemical risk factors. Urol Res 39:1–7PubMedCrossRef
25.
Zurück zum Zitat Tothova L, Celec P, Ostatnikov D, Okuliarova M, Zeman M, Hodosy J (2012) Effect of exogenous testosterone on oxidative status of the testes in adult male rats. Andrologia. doi: 10.1111/and.12032 Tothova L, Celec P, Ostatnikov D, Okuliarova M, Zeman M, Hodosy J (2012) Effect of exogenous testosterone on oxidative status of the testes in adult male rats. Andrologia. doi: 10.​1111/​and.​12032
Metadaten
Titel
Antioxidants inhibition of high plasma androgenic markers in the pathogenesis of ethylene glycol (EG)-induced nephrolithiasis in Wistar rats
verfasst von
Mohammad Reza Naghii
Mahmood Mofid
Mehdi Hedayati
Kazem Khalagi
Publikationsdatum
01.04.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Urolithiasis / Ausgabe 2/2014
Print ISSN: 2194-7228
Elektronische ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-013-0620-5

Weitere Artikel der Ausgabe 2/2014

Urolithiasis 2/2014 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

Stufenschema weist Prostatakarzinom zuverlässig nach

22.04.2024 Prostatakarzinom Nachrichten

Erst PSA-Test, dann Kallikrein-Score, schließlich MRT und Biopsie – ein vierstufiges Screening-Schema kann die Zahl der unnötigen Prostatabiopsien erheblich reduzieren: Die Hälfte der Männer, die in einer finnischen Studie eine Biopsie benötigten, hatte einen hochgradigen Tumor.

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

20.04.2024 EAU 2024 Kongressbericht

Beim chronischen Harnwegsinfekt bei Frauen wird bisher meist eine Antibiotikaprophylaxe eingesetzt. Angesichts der zunehmenden Antibiotikaresistenz erweist sich das Antiseptikum Methenamin-Hippurat als vielversprechende Alternative, so die Auswertung einer randomisierten kontrollierten Studie.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.